These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18379831)

  • 21. Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.
    Lindgren P; Geborek P; Kobelt G
    Int J Technol Assess Health Care; 2009 Apr; 25(2):181-9. PubMed ID: 19331709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
    Roe RH; Lass JH; Brown GC; Brown MM
    Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised comparison of costs and cost-effectiveness of cryostripping and endovenous laser ablation for varicose veins: 2-year results.
    Disselhoff BC; Buskens E; Kelder JC; der Kinderen DJ; Moll FL
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):357-63. PubMed ID: 19111485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome and quality-adjusted life years after severe sepsis.
    Karlsson S; Ruokonen E; Varpula T; Ala-Kokko TI; Pettilä V;
    Crit Care Med; 2009 Apr; 37(4):1268-74. PubMed ID: 19242321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
    Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
    Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Financing in knee arthroplasty: a benchmarking analysis.
    Effenberger H; Rehart S; Zumstein MD; Schuh A
    Arch Orthop Trauma Surg; 2008 Dec; 128(12):1349-56. PubMed ID: 18309508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions.
    Kobelt G; Texier-Richard B; Lindgren P
    Mult Scler; 2009 Jun; 15(6):741-51. PubMed ID: 19383645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gait and balance of transfemoral amputees using passive mechanical and microprocessor-controlled prosthetic knees.
    Kaufman KR; Levine JA; Brey RH; Iverson BK; McCrady SK; Padgett DJ; Joyner MJ
    Gait Posture; 2007 Oct; 26(4):489-93. PubMed ID: 17869114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness and economic impact of the KineSpring® Knee Implant System in the treatment of knee osteoarthritis in Italy.
    Marcacci M; Zaffagnini S; Li CS; Bhandari M
    J Long Term Eff Med Implants; 2013; 23(2-3):211-22. PubMed ID: 24579860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technology: a growing cost in knee implant surgeries.
    Mendenhall S
    Healthc Financ Manage; 1989 Apr; 43(4):46, 48-50. PubMed ID: 10312914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of microprocessor-controlled prosthetic knees.
    Dillon M; Ratcliffe J
    Arch Phys Med Rehabil; 2010 Apr; 91(4):663; author reply 664. PubMed ID: 20382304
    [No Abstract]   [Full Text] [Related]  

  • 39. Emerging robotics technology and its transformation of practices in healthcare.
    Merlyn PR
    Stud Health Technol Inform; 1997; 39():572-82. PubMed ID: 10173069
    [No Abstract]   [Full Text] [Related]  

  • 40. Designing for scale: development of the ReMotion Knee for global emerging markets.
    Hamner SR; Narayan VG; Donaldson KM
    Ann Biomed Eng; 2013 Sep; 41(9):1851-9. PubMed ID: 23525749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.